Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
146.4 USD | -0.03% |
|
-0.46% | -4.75% |
28/06 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
28/06 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock
- News Johnson & Johnson
- Press Releases